发明名称 Microbial production of natural sweeteners, diterpenoid steviol glycosides
摘要 The invention relates to recombinant expression of a steviol or steviol glycosides biosynthetic pathway enzymes in cells and the production of steviol or steviol glycosides.
申请公布号 US9284570(B2) 申请公布日期 2016.03.15
申请号 US201113306633 申请日期 2011.11.29
申请人 Massachusetts Institute of Technology 发明人 Stephanopoulos Gregory;Ajikumar Parayil K.
分类号 C12P15/00;C12N9/90;C12N9/88;C12N9/10;C12N9/02;C12N9/12;C12N15/00;C12N1/20;C07H21/04;C12N15/82;C12N15/70;A01H5/00;A01H13/00;A23L1/236;A23L2/60;C12P7/42;C12P17/02 主分类号 C12P15/00
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method for producing steviol or steviol glycoside comprising: culturing an E. coli strain having balanced expression of (1) an upstream methylerythritol pathway (MEP) that produces isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), with respect to (2) a downstream pathway that produces steviol or steviol glycoside from said IPP and DMAPP, the downstream pathway comprising a recombinantly expressed copalyl diphosphate synthase (CPS), kaurene synthase (KS), a geranylgeranyl diphosphate synthase (GGPPS) kaurenoic acid 13-hydroxylase (KAH) and kaurene oxidase (KO), and optionally one or more Stevia UDP glycosyl transferase enzymes; wherein said balanced expression is obtained by increasing or decreasing the expression level of a downstream pathway module and increasing or decreasing the expression level of an upstream pathway module together in E. coli, and identifying an E. coli strain with higher production of steviol or steviol glycoside and/or lower accumulation of indole as having balanced expression.
地址 Cambridge MA US